Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 12/20 | 0.69 |
| ▸ | ADORA3 | P0DMS8 | 10/20 | 0.69 |
| ▸ | ADORA1 | P30542 | 9/20 | 0.69 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.69 |
| ▸ | CSNK1D | P48730 | 2/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9327282 | 0.81 | ADORA2A (1.00) | ADORA2AADORA3ADORA1ADORA2BCSNK1D | |
| SCHEMBL9326962 | 0.80 | ADORA2A (0.98) | ADORA2AADORA3ADORA1ADORA2BCSNK1D | |
| SCHEMBL9327228 | 0.77 | ADORA2A (0.67) | ADORA2AADORA3ADORA1ADORA2BCSNK1D | |
| SCHEMBL9329574 | 0.75 | ADORA2A (0.64) | ADORA2AADORA3ADORA1ADORA2BCSNK1D | |
| SCHEMBL9328945 | 0.71 | ADORA3 (0.64) | ADORA2AADORA3ADORA1ADORA2B | |
| SCHEMBL5408777 | 0.68 | ADORA2A (0.71) | ADORA2AADORA3ADORA1ADORA2B | |
| SCHEMBL6869733 | 0.68 | ADORA2A (0.52) | ADORA2A | |
| SCHEMBL5416151 | 0.65 | ADORA2A (0.66) | ADORA2AADORA3ADORA1ADORA2B | |
| SCHEMBL9327137 | 0.63 | ADORA2A (0.50) | ADORA2AADORA3ADORA1ADORA2B | |
| SCHEMBL9325961 | 0.63 | ADORA2A (0.67) | ADORA2AADORA3ADORA1ADORA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5356894-A | Adenosine antagonists | SYNGENTA LIMITED (GB) | 1994-10-18 | — | — | US | disclosed |
| EP-0459702-A1 | Azole Derivatives | ZENECA LIMITED (GB) | 1991-12-04 | — | — | EP | disclosed |